BUPRENORPHINE MARKET ANALYSIS
The global buprenorphine market is estimated to be valued at US$ 5.52 Billion in 2023 and is expected to exhibit a CAGR of 14.9% during the forecast period (2023-2030).
Figure 1. Global Buprenorphine Market Share (%), by Application, 2023
Global Buprenorphine Market – Driver
Approval of Buprenorphine Treatment for Opioid Use Disorder, by Regulatory Authorities
Increasing approval of buprenorphine treatment for opioid use disorder by regulatory authorities is expected to drive the growth of the global buprenorphine market over the forecast period. For instance, on May 23, 2023, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use to treat moderate to severe opioid use disorder. Brixadi is available in two formulations: a weekly injection...
Figure 2. Global Buprenorphine Market Share (%), by Region, 2023
Global Buprenorphine Market – Market-Trends
Based on application, the market is segmented into analgesic and opioid antagonist. Out of which, the opioid antagonist segment is expected to hold a dominant position...
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowPress Release
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
